By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



29 Emmons Drive
Suite C-10
Princeton  New Jersey  08540  U.S.A.
Phone: 609-538-8200 Fax: 609-452-6467


Company News
Soligenix (SNGX) Announces Combination Vaccine For Ricin And Anthrax Achieves Simultaneous Protection 7/9/2014 10:01:59 AM
Soligenix (SNGX) Reports First Quarter 2014 Financial Results, And Highlights Recent Accomplishments 5/12/2014 6:12:35 AM
Soligenix (SNGX) Announces $200,000 NIDCR SBIR Grant Award Supporting Phase 2 Clinical Trial Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer 4/7/2014 9:58:01 AM
Soligenix (SNGX) Reports Year-End 2013 Financial Results And Highlights Recent Accomplishments 3/26/2014 6:23:46 AM
Vista Partners Initiates Coverage On Soligenix (SNGX); $5.50 Price Target 3/19/2014 9:46:32 AM
Soligenix (SNGX.OB) To Present At 2014 World Vaccine Congress In Washington, DC 3/11/2014 6:19:42 AM
Soligenix (SNGX.OB) Announces $300,000 NIAID SBIR Grant Award Supporting Further Evaluation Of SGX943 As A Treatment For Melioidosis 2/14/2014 9:14:09 AM
Soligenix (SNGX.OB) To Present At The 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference In New York City 2/5/2014 6:39:28 AM
Soligenix (SNGX.OB) Receives $750,000 In Non-Dilutive Financing From New Jersey's Technology Business Tax Certificate Transfer Program 1/16/2014 10:18:18 AM
Soligenix (SNGX.OB) Announces Positive One-Year High-Temperature Stability Results With ThermoVax™ Vaccine Heat Stabilization Technology 1/15/2014 8:08:35 AM